Companies / Lucid Diagnostics Inc.

Lucid Diagnostics Inc.

Nasdaq: LUCDCIK 1799011NEW YORK, NY

Financials · FY2024

Revenue$4.35M
Net income$-58.01M
Total debt$24.28M
Cash$47.33M
Diluted EPS$-1.05
Shares outstanding203.2M

Ownership

203.2M shares outstanding · as of Aug 10, 2026
5.2%Insiders
Ownership
Insiders5.24%10,642,634
Institutions18.39%37,368,532
Public float76.38%155,232,804

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 11

View all →
Insider% of sharesShares
Aklog LishanCEOChief Executive Officer · Director
1.79%3,636,627
McGrath Dennis MChief Financial Officer
0.89%1,813,569
O'Neil ShaunPresident and COO
0.71%1,446,763
Gordon Michael AdamGeneral Counsel and Secretary
0.49%1,000,000
0.39%788,443
Cox James LDirector
0.20%405,120
0.17%338,000
0.17%337,392
0.16%320,460
0.16%320,460

Institutional holders 93

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 20, 2026Matheis Dennis
Director
GrantCommon Stock$0+123K
+18.48%
788,443
0.39% of shares
low
Feb 20, 2026Aklog Lishan
CEO
GrantCommon Stock$0+2.2M
+147.96%
3,636,627
1.79% of shares
low
Feb 20, 2026White Debra
Director
GrantCommon Stock$0+123K
+109.04%
235,800
0.12% of shares
low
Feb 20, 2026Sparks Ronald M
Director
GrantCommon stock$0+123K
+62.29%
320,460
0.16% of shares
low
Feb 20, 2026Sokolov Jacque J
Director
GrantCommon Stock$0+123K
+62.29%
320,460
0.16% of shares
low
Feb 20, 2026Palumbo John R
Director
GrantCommon Stock$0+123K
+57.21%
338,000
0.17% of shares
low
Feb 20, 2026Lapidus Stanley
Director
GrantCommon Stock$0+123K
+57.37%
337,392
0.17% of shares
low
Feb 20, 2026Cox James L
Director
GrantCommon Stock$0+123K
+43.60%
405,120
0.20% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
LUCDCommon StockEquity54948X109BBG012NYMLC0